Cargando…

Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis

OBJECTIVE: To clarify the application value of 5-hydroxymethylcytosine (5hmC) in evaluating the progression of chronic hepatitis B (CHB) to hepatocellular carcinoma (HCC) based on difference analysis. METHODS: A total of 180 patients were enrolled. Among them, 84 patients with chronic hepatitis B vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jiao, Gao, Guofeng, Wang, Jing, Zhao, Jieqiong, Zhang, Yu, Jiang, Dong, Huang, Feihu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150989/ https://www.ncbi.nlm.nih.gov/pubmed/35651922 http://dx.doi.org/10.1155/2022/4835417

Ejemplares similares

Retracted: Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Role of ten‐eleven translocation proteins and 5‐hydroxymethylcytosine in hepatocellular carcinoma
por: Wang, Penghui, et al.
Publicado: (2019)

Association of 5-Methylcytosine and 5-Hydroxymethylcytosine with Mitochondrial DNA Content and Clinical and Biochemical Parameters in Hepatocellular Carcinoma
por: Shen, Fan, et al.
Publicado: (2013)

Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1
por: Liu, Chungang, et al.
Publicado: (2013)

5-hydroxymethylcytosine and gene activity in mouse intestinal differentiation
por: Uribe-Lewis, Santiago, et al.
Publicado: (2020)

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma
por: Barazeghi, Elham, et al.
Publicado: (2016)

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis
por: Guo, Xiao-Jun, et al.
Publicado: (2023)

Decrease of 5-hydroxymethylcytosine in hepatitis B virus-related hepatocellular carcinoma: A cross-sectional study
por: Jia, Yansheng, et al.
Publicado: (2023)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

5-Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma
por: Tong, Mengying, et al.
Publicado: (2019)

Physiological and pathological implications of 5-hydroxymethylcytosine in diseases
por: Liang, Jing, et al.
Publicado: (2016)

Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma
por: Liu, Youde, et al.
Publicado: (2020)

The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing
por: Huang, Yun, et al.
Publicado: (2010)

Alterations of 5-Hydroxymethylcytosine in Human Cancers
por: Mariani, Christopher J., et al.
Publicado: (2013)

Formation and Abundance of 5-Hydroxymethylcytosine in RNA
por: Huber, Sabrina M, et al.
Publicado: (2015)

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
por: Stahl, Alexandre, et al.
Publicado: (2021)

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
por: Sjöström, Martin, et al.
Publicado: (2022)

TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma
por: Murata, Asuka, et al.
Publicado: (2015)

5-Hydroxymethylcytosine and ten-eleven translocation dioxygenases in head and neck carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma
por: Shi, Xuejiao, et al.
Publicado: (2016)

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor differentiation
por: Si, Yuan-Quan, et al.
Publicado: (2020)

Tissue-specific 5-hydroxymethylcytosine landscape of the human genome
por: He, Bo, et al.
Publicado: (2021)

Genome-wide 5-hydroxymethylcytosine modification pattern is a novel epigenetic feature of globozoospermia
por: Wang, Xiu-Xia, et al.
Publicado: (2015)

5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function
por: Stoyanova, Elitsa, et al.
Publicado: (2021)

Reappraisal of the diagnostic value of alpha‐fetoprotein for surveillance of HBV‐related hepatocellular carcinoma in the era of antiviral therapy
por: Qian, Xiangjun, et al.
Publicado: (2020)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Genomic mapping of 5-hydroxymethylcytosine in the human brain
por: Jin, Seung-Gi, et al.
Publicado: (2011)

Distribution of 5-Hydroxymethylcytosine in Different Human Tissues
por: Li, Weiwei, et al.
Publicado: (2011)

Tet-Mediated Formation of 5-Hydroxymethylcytosine in RNA
por: Fu, Lijuan, et al.
Publicado: (2014)

The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases
por: Al-Mahdawi, Sahar, et al.
Publicado: (2014)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma
por: Cai, Z., et al.
Publicado: (2021)

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
por: Cai, Jiabin, et al.
Publicado: (2019)

Association of CD44 polymorphisms and susceptibility to HBV‐related hepatocellular carcinoma in the Chinese population
por: Deng, Yan, et al.
Publicado: (2019)

Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma
por: Hong, Ying-Fen, et al.
Publicado: (2017)

TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer
por: Chapman, Christopher G., et al.
Publicado: (2015)

Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
por: Tekpli, Xavier, et al.
Publicado: (2016)

Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study
por: Chen, Song, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oidjh062loikp97tg5apsmieo5